Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review

被引:11
|
作者
Coste, Astrid [1 ]
Wong, Angel [1 ]
Bokern, Marleen [1 ]
Bate, Andrew [1 ,2 ]
Douglas, Ian J. [1 ]
机构
[1] LSHTM, Dept Noncommunicable Dis Epidemiol, London, England
[2] Global Safety, Brentford, England
关键词
drug safety surveillance; pharmacoepidemiology; pharmacovigilance; real world data; signal detection; systematic review; CONTROLLED CASE SERIES; SPONTANEOUS REPORTING DATABASE; SEQUENCE SYMMETRY ANALYSIS; LONGITUDINAL DATABASES; EMPIRICAL-ASSESSMENT; RISK IDENTIFICATION; ADVERSE EVENTS; SURVEILLANCE; CLAIMS; RECORDS;
D O I
10.1002/pds.5548
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Signal detection is a crucial step in the discovery of post-marketing adverse drug reactions. There is a growing interest in using routinely collected data to complement established spontaneous report analyses. This work aims to systematically review the methods for drug safety signal detection using routinely collected healthcare data and their performance, both in general and for specific types of drugs and outcomes. Methods We conducted a systematic review following the PRISMA guidelines, and registered a protocol in PROSPERO. MEDLINE, EMBASE, PubMed, Web of Science, Scopus, and the Cochrane Library were searched until July 13, 2021. Results The review included 101 articles, among which there were 39 methodological works, 25 performance assessment papers, and 24 observational studies. Methods included adaptations from those used with spontaneous reports, traditional epidemiological designs, methods specific to signal detection with real-world data. More recently, implementations of machine learning have been studied in the literature. Twenty-five studies evaluated method performances, 16 of them using the area under the curve (AUC) for a range of positive and negative controls as their main measure. Despite the likelihood that performance measurement could vary by drug-event pair, only 10 studies reported performance stratified by drugs and outcomes, in a heterogeneous manner. The replicability of the performance assessment results was limited due to lack of transparency in reporting and the lack of a gold standard reference set. Conclusions A variety of methods have been described in the literature for signal detection with routinely collected data. No method showed superior performance in all papers and across all drugs and outcomes, performance assessment and reporting were heterogeneous. However, there is limited evidence that self-controlled designs, high dimensional propensity scores, and machine learning can achieve higher performances than other methods.
引用
收藏
页码:28 / 43
页数:16
相关论文
共 48 条
  • [21] Accuracy of heart failure ascertainment using routinely collected healthcare data: a systematic review and meta-analysis
    Michelle. A. Goonasekera
    Alison Offer
    Waseem Karsan
    Muram El-Nayir
    Amy E. Mallorie
    Sarah Parish
    Richard J. Haynes
    Marion M. Mafham
    Systematic Reviews, 13
  • [22] Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review
    Jiao, Xue-Feng
    Pu, Libin
    Lan, Shan
    Li, Hailong
    Zeng, Linan
    Wang, Huiqing
    Zhang, Lingli
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (03)
  • [23] Automated Deterioration Detection Using Electronic Medical Record Data in Intensive Care Unit Patients A Systematic Review
    Despins, Laurel A.
    CIN-COMPUTERS INFORMATICS NURSING, 2018, 36 (07) : 323 - 330
  • [24] Understanding patterns of care for musculoskeletal patients using routinely collected National Health Service data from general practices in England
    Smith, Chris
    Hewison, Jenny
    West, Robert M.
    Kingsbury, Sarah R.
    Conaghan, Philip G.
    HEALTH INFORMATICS JOURNAL, 2020, 26 (04) : 2470 - 2484
  • [25] Automated Detection of Sepsis Using Electronic Medical Record Data: A Systematic Review
    Despins, Laurel A.
    JOURNAL FOR HEALTHCARE QUALITY, 2017, 39 (06) : 322 - 333
  • [26] Pediatric Drug Safety Signal Detection: A New Drug-Event Reference Set for Performance Testing of Data-Mining Methods and Systems
    Osokogu, Osemeke U.
    Fregonese, Federica
    Ferrajolo, Carmen
    Verhamme, Katia
    de Bie, Sandra
    't Jong, Geert
    Catapano, Mariana
    Weibel, Daniel
    Kaguelidou, Florentia
    Bramer, Wichor M.
    Hsia, Yingfen
    Wong, Ian C. K.
    Gazarian, Madlen
    Bonhoeffer, Jan
    Sturkenboom, Miriam
    DRUG SAFETY, 2015, 38 (02) : 207 - 217
  • [27] Signal Detection of Pediatric Drug-Induced Coagulopathy Using Routine Electronic Health Records
    Nie, Xiaolu
    Yu, Yuncui
    Jia, Lulu
    Zhao, Houyu
    Chen, Zhenping
    Zhang, Liqiang
    Cheng, Xiaoling
    Lyu, Yaqi
    Cao, Wang
    Wang, Xiaoling
    Peng, Xiaoxia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Towards Sustainable Public Health Surveillance in India: Using Routinely Collected Electronic Emergency Medical Service Data for Early Warning of Infectious Diseases
    Pilot, Eva
    Roa, Ramana
    Jena, Biranchi
    Kauhl, Boris
    Krafft, Thomas
    Murthy, G. V. S.
    SUSTAINABILITY, 2017, 9 (04):
  • [29] Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records
    Sun, Cuicui
    Zhao, Lixia
    Yuan, Yujie
    Xiang, Yanxiao
    Liu, Anchang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (04) : 416 - 425
  • [30] Toward an Interdisciplinary Approach to Constructing Care Delivery Pathways From Electronic Health Care Databases to Support Integrated Care in Chronic Conditions: Systematic Review of Quantification and Visualization Methods
    do Prado, Luiza Siqueira
    Allemann, Samuel
    Viprey, Marie
    Schott, Anne-Marie
    Dediu, Dan
    Dima, Alexandra Lelia
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25